Dijkmans, A.C.; ZacarÃas, N.V.O.; Burggraaf, J.; Mouton, J.W.; Wilms, E.B.; Van Nieuwkoop, C.; Touw, D.J.; Stevens, J.; Kamerling, I.M.C.
Fosfomycin: Pharmacological, Clinical and Future Perspectives. Antibiotics 2017, 6, 24.
https://doi.org/10.3390/antibiotics6040024
AMA Style
Dijkmans AC, ZacarÃas NVO, Burggraaf J, Mouton JW, Wilms EB, Van Nieuwkoop C, Touw DJ, Stevens J, Kamerling IMC.
Fosfomycin: Pharmacological, Clinical and Future Perspectives. Antibiotics. 2017; 6(4):24.
https://doi.org/10.3390/antibiotics6040024
Chicago/Turabian Style
Dijkmans, Anneke Corinne, Natalia Veneranda Ortiz ZacarÃas, Jacobus Burggraaf, Johan Willem Mouton, Erik Bert Wilms, Cees Van Nieuwkoop, Daniel Johannes Touw, Jasper Stevens, and Ingrid Maria Catharina Kamerling.
2017. "Fosfomycin: Pharmacological, Clinical and Future Perspectives" Antibiotics 6, no. 4: 24.
https://doi.org/10.3390/antibiotics6040024
APA Style
Dijkmans, A. C., ZacarÃas, N. V. O., Burggraaf, J., Mouton, J. W., Wilms, E. B., Van Nieuwkoop, C., Touw, D. J., Stevens, J., & Kamerling, I. M. C.
(2017). Fosfomycin: Pharmacological, Clinical and Future Perspectives. Antibiotics, 6(4), 24.
https://doi.org/10.3390/antibiotics6040024